Literature DB >> 11749691

Decreased expression of Bcl-x protein during hepatocarcinogenesis induced exogenously and endogenously in rats.

Y Hatanaka1, D Nakae, M Mutai, K Hashizume, Y Kamihara, N Kinoshita, Y Tani, G Danno Gi, S Ohta, Y Konishi, H Ashida.   

Abstract

Dysregulations of apoptosis have been widely recognized as important events in multi-stage carcinogenesis. Bcl-x, a member of the Bcl-2 family, is known to act as a regulator of apoptosis. The present study was conducted to assess the role of altered Bcl-x protein expression in exogenous and endogenous hepatocarcinogenesis in rats. In the short-term exogenous models, male Fischer 344 rats, 6 weeks old, were given a single intraperitoneal injection of diethylnitrosamine (DEN) at a dose of 200 mg / kg body weight, partially hepatectomized at the end of week 3, administered phenobarbital at a concentration of 0.05% from the end of week 2 for 6 weeks, and sacrificed. In the livers, glutathione S-transferase (GST-P)-positive, putative preneoplastic lesions were induced, and Bcl-x protein expression was decreased in 24.7% of such lesions. The incidence of GST-P-positive lesions with decreased Bcl-x increased depending on the size of the lesions; 18.9%, 32.4% and 86.5% in the lesions smaller than 0.03, between 0.03 and 0.3, and larger than 0.3 mm(2), respectively. In GST-P-positive lesions larger than 0.3 mm(2), both apoptosis induction and cell proliferation activity were enhanced when Bcl-x protein expression was decreased. In the long-term exogenous models, rats were given 10 mg / kg of DEN, partially hepatectomized 4 h after treatment, administered 0.5 mg / kg of colchicine at the end of days 1 and 3, subjected to a selection procedure, and sacrificed at the end of week 45. Hepatocellular carcinomas were induced with the decreased Bcl-x protein expression. In the endogenous model, rats were fed a choline-deficient, L-amino acid-defined diet for 16 or 80 weeks and sacrificed. Bcl-x protein expression was decreased both in GST-P-positive lesions and hepatocellular carcinoma. These results suggest that this decrease of Bcl-x protein might serve as an indicator of the advanced form of preneoplastic lesions, and that this decrease could also be associated with a potential to progress into carcinoma in both exogenous and endogenous hepatocarcinogenesis of rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749691      PMCID: PMC5926673          DOI: 10.1111/j.1349-7006.2001.tb02149.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


hepatocellular carcinoma diethylnitrosamine choline‐deficient, l‐amino acid‐defined diet enzyme‐linked immunosorbent assay glutathione‐S‐transferase placental form single‐stranded DNA proliferating cell nuclear antigen topoisomerase II alpha partial hepatectomy hematoxylin and eosin terminal deoxynucleotidyl transferase‐mediated deoxyuridine triphosphate‐biotin nick end labeling reactive oxygen species
  31 in total

1.  Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.

Authors:  A Srinivasan; F Li; A Wong; L Kodandapani; R Smidt; J F Krebs; L C Fritz; J C Wu; K J Tomaselli
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

2.  Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).

Authors:  A Frankel; K Rosen; J Filmus; R S Kerbel
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

3.  Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Authors:  M Krajewska; S F Moss; S Krajewski; K Song; P R Holt; J C Reed
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

4.  Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.

Authors:  J G Christensen; E H Romach; L N Healy; A J Gonzales; S P Anderson; D E Malarkey; J C Corton; T R Fox; R C Cattley; T L Goldsworthy
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

5.  Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicine-induced cell cycle disturbance in partially hepatectomized rats.

Authors:  K Ohashi; M Tsutsumi; T Tsujiuchi; K Kobitsu; E Okajima; Y Nakajima; H Nakano; M Takahashi; Y Mori; Y Konishi
Journal:  Cancer Res       Date:  1996-08-01       Impact factor: 12.701

6.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

7.  Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues.

Authors:  K Ohta; K Iwai; Y Kasahara; N Taniguchi; S Krajewski; J C Reed; T Miyawaki
Journal:  Int Immunol       Date:  1995-11       Impact factor: 4.823

8.  Immunohistochemical analysis of in vivo patterns of Bcl-X expression.

Authors:  S Krajewski; M Krajewska; A Shabaik; H G Wang; S Irie; L Fong; J C Reed
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P positive liver cell focus as an endpoint marker.

Authors:  N Ito; M Tatematsu; R Hasegawa; H Tsuda
Journal:  Toxicol Pathol       Date:  1989       Impact factor: 1.902

10.  Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats.

Authors:  Y Sasaki; T Tsujiuchi; N Murata; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2001-01
View more
  2 in total

Review 1.  Prevention of liver cancer.

Authors:  Kathryn Z Guyton; Thomas W Kensler
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

2.  The effect of N-nitrosodimethylamine (NDMA) on Bax and Mcl-1 expression in human neutrophils.

Authors:  Jakub Jablonski; Ewa Jablonska; Agnieszka Leonik
Journal:  Bull Environ Contam Toxicol       Date:  2011-09-27       Impact factor: 2.151

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.